Use of xenon for the control of neurological deficits...

Details Use of xenon for the control of neurological deficits... Use of xenon for the control of neurological deficits...

2003-05-01

2008-10-28

Richter, Johann (Department: 1616)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

C514S816000, C514S958000

Reexamination Certificate

active

07442383

ABSTRACT:
The present invention relates to methods of controlling neurological deficits in patients who have undergone cardiopulmonary bypass (CPB) by administering xenon to said patients.

REFERENCES:
patent: 6197323 (2001-03-01), Georgieff
patent: WO 00/53192 (2000-09-01), None
patent: WO-00/53192 (2000-09-01), None
patent: WO 00/76545 (2000-12-01), None
patent: WO 01/08692 (2001-02-01), None
Johnsson et al. Ann Thorac Surg 1991, 51, 579-84.
Gardner et al., Stroke Following Coronary Artery Bypass Grafting: A Ten-Year Study, The Annals of Thoracic Surgery, vol. 40, No. 6, Dec. 1985, XP009015316.
Grocott et al., Neurological Injury During Cardiopulmonary Bypass in the Rat, Perfusion 2001; 16: 75-91, XP009015397.
Ma, et al., Xenon Attenuates Cardiopulmonary Bypass-Induced Neurologic and Neurocognitive Dysfunction in the Rat, 2002 ASA Meeting Abstracts, Oct. 2002, XP-001154264.

Affiliated with

Also associated with

Rating

Use of xenon for the control of neurological deficits... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of xenon for the control of neurological deficits..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of xenon for the control of neurological deficits... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3997806